Adaptin Bio has received FDA clearance to initiate a Phase 1 clinical trial for its investigational drug APTN-101, a...

Foundation Medicine and Syndax Pharmaceuticals have initiated a partnership to develop a tool to identify acute myeloid leukemia (AML)...

Atamyo Therapeutics and the Dion Foundation for Rare Diseases have partnered to conduct a clinical trial in the United...

Patient recruitment and retention are among the most critical challenges in the fast-evolving world of clinical trials. In 2000,...

Histotripsy, a groundbreaking non-invasive therapy, has gained significant momentum following its FDA clearance. Pivotal clinical trials revealed its exceptional...

AngioDynamics has secured CE Mark approval for its innovative Auryon Atherectomy System, a groundbreaking technology for treating Peripheral Artery...

Medincell has partnered with AbbVie to develop and commercialize up to six innovative therapies using Medincell’s long-acting injectable platform....

The European Commission (EC) has granted approval to the combination of KEYTRUDA (pembrolizumab) and Padcev (enfortumab vedotin) as a...

Pyros Pharmaceuticals introduces VIGAFYDE™, an oral solution containing vigabatrin for treating infantile spasms (IS) in children aged 1 month...

Medidata, a renowned provider of clinical trial solutions, has partnered with Aixial Group, a contract research organization (CRO), to...